News

Quince Therapeutics Webinar to Address Ataxia-Telangiectasia Needs

Quince Therapeutics Webinar to Address Ataxia-Telangiectasia Needs

Upcoming Webinar on Ataxia-Telangiectasia by Quince Therapeutics

Quince Therapeutics, Inc. (Nasdaq: QNCX), a biotechnology company committed to utilizing the unique power of a patient’s own biology, is set to host a virtual investor webinar dedicated to the urgent unmet needs associated with Ataxia-Telangiectasia (A-T). This significant event is scheduled for February 7, 2025, beginning at 10:00 a.m. Eastern Time.

Expert Insights on A-T

During the webinar, attendees will gain valuable insights from Dr. Mary Kay Koenig, a recognized leader in A-T research. Dr. Koenig is expected to cover several key topics, including: an overview of A-T's natural history, current treatment strategies, an analysis of the competitive therapeutic landscape, and details on Quince’s Phase 3 clinical trial of EryDex for A-T treatment. Additionally, Dirk Thye, M.D., who serves both as the Chief Executive Officer and Chief Medical Officer at Quince, will participate to share a comprehensive update on the company, including insights on ongoing clinical trials.

Recognized Leadership in Pediatric Neurodegenerative Disorders

Dr. Mary Kay Koenig brings a wealth of knowledge and experience to the table. As a board-certified child neurologist specializing in various neurodegenerative conditions, her role at the McGovern Medical School at the University of Texas in Houston emphasizes advancing research and clinical care for children affected by genetic disorders. Dr. Koenig's dedication to mentoring future medical professionals also speaks volumes about her commitment to the field.

Register and Participate

Those interested in this informative webinar can register through Quince's official channels. A live broadcast of the event will be accessible on Quince’s Events page, allowing participants to engage with the content comprehensively. Following the event, an archived recording will be available for those who may want to revisit the discussions at a later time.

About Quince Therapeutics

Quince Therapeutics, Inc. (Nasdaq: QNCX) is dedicated to pioneering approaches to treating rare diseases by leveraging the intrinsic biology of the patient. Their mission to provide innovative therapies is reflected in their robust clinical pipeline. For further information regarding their initiatives, visit their official website and engage with them on various social media platforms.

Frequently Asked Questions

What is the main focus of the Quince Therapeutics webinar?

The webinar will address the high unmet need in the treatment of Ataxia-Telangiectasia.

Who is Dr. Mary Kay Koenig?

Dr. Koenig is a board-certified child neurologist specializing in neurodegenerative disorders, providing crucial insights for the webinar.

When is the webinar scheduled?

The webinar is set for February 7, 2025, at 10:00 a.m. Eastern Time.

How can I register for the webinar?

Participants can register for the webinar by visiting Quince Therapeutics' official website and following the registration link.

What will Dr. Koenig discuss during the event?

She will cover A-T’s natural history, treatment approaches, and details on the Phase 3 clinical trial of EryDex.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Arbor Scientia Snags Second Consecutive BASA Win

Updated Category News Views 9

Picture a small business breaking into the spotlight, grabbing the industry’s attention two years in a row: That’s the story of Arbor Scientia Group (ASG), bagging its second consecutive BASA Award. Celebrated within the Education and Training category, this global medical education and communications agency—not just a regular name in the field—has made measurable...

Continue Reading
Cecilia Vicuña's Bold Exhibition at MOCA Tackles Water Crisis

Updated Category News Views 0

Art and ecological awareness dance together on a tightrope at the Museum of Contemporary Art (MOCA) in Los Angeles. Cecilia Vicuña’s new exhibition, The Dream of Water: Quipu of Encounters Maricunga, arrives with a punch, not merely as art but as a call to arms for water conservation and environmental justice. The show kicks off on November 15, 2026, and remains open...

Continue Reading
Primoris Faces Allegations Over Misleading Project Costs

Updated Category News Views 0

Primoris in the Legal Crosshairs Here's something that's bound to rile up any investor keeping tabs on NYSE: PRIM like it's their personal stock ticker. Apparently, Primoris Services Corporation has found itself neck-deep in some murky waters. This time, it's law firm Moore Law PLLC that's raising the alarm bells, calling on shareholders to step into the legal ring....

Continue Reading
AHN Opens Clinic for Severe Postpartum Tear Care

Updated Category News Views 4

A Game Changer for Postpartum Recovery When it comes to childbirth, you think you've heard it all, but here's a twist—Allegheny Health Network (AHN) just swung the doors open on a clinic laser-focused on a very raw deal: third- and fourth-degree perineal lacerations. We're diving into new territory where one network sees the gap and jumps into action, calling in the...

Continue Reading
Ademi LLP Investigates Braze Buyout Concerns for Investors

Updated Category News Views 3

Scrutinizing Braze's $5.66 Billion Salesforce Deal There's a shake-up brewing in the world of tech buyouts, and it's hitting home with Braze, Inc. (NASDAQ: BRZE). On the surface, a $47.50 per share all-cash offer from Salesforce might look like a shiny deal, totalling up to a robust $5.66 billion valuation. However, Ademi LLP, a law firm no stranger to corporate scrutiny,...

Continue Reading
Prosecco DOC Chef Residency Debriefs on Inaugural Year

Updated Category News Views 2

A Fusion of Flavors: The Residency Recap Alright, listen up. The Prosecco DOC Chef Residency has wrapped its initial bash in Italy, where it played culinary matchmaker with talents from Brazil, South Korea, Canada, and the UK. Picture some top-notch chefs crossing borders and tweaking recipes with that unique Italian spark of Prosecco DOC. It wasn't just some ballroom...

Continue Reading
ALS.Community Launches Free Online Support Platform

Updated Category News Views 11

A Long Path to Connection Sometimes it's easy to forget the power a community can wield until you see one rally around a cause. The launch of ALS.Community isn't just a digital debut; it's a testament to how collective understanding can be a lifeline. For folks grappling with amyotrophic lateral sclerosis (ALS), beating solitude is often half the battle. Founder Jeff...

Continue Reading
Harry Ritchie's Marks 70th Anniversary with Charity Event

Updated Category News Views 1

You don't sniff 70 years in retail without sewing some sturdy community threads. Harry Ritchie's, a stalwart in Eugene, Oregon's retail scene, just pulled a classic move: celebrating their seven-decade milestone by feeding folks instead of throwing a gala. In a world where local shops often vanish like ghosts, they're sticking with the founder's mantra from 1956: Be...

Continue Reading
Life After Debt: Freedom, Confidence, and Wellbeing

Updated Category News Views 6

The Unseen Upside of Financial Freedom Debt can feel like a ball and chain, dragging down everything from your sleep to your relationships. But shred that debt, and suddenly the world looks different. Accredited Debt Relief's recent survey of 1,000 folks who've paid off at least $5,000 in unsecured debt uncovers the remarkable transformations that follow. According to 93%...

Continue Reading
Innventure Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 0

Legal Troubles Mount for Innventure, Inc. Looks like Innventure, Inc. is caught in the kind of mess that even seasoned traders dread—a class action lawsuit hanging over its head like a storm cloud just bursting with lightning. If you're holding a piece of Innventure (NASDAQ: INV), this is one of those times when you've got to look your portfolio straight in the eye and...

Continue Reading

Top 5 Most Recently Viewed Articles

Kornit Digital Leads The Shift to On-Demand Fashion Solutions

Updated Category News Views 72

Kornit Digital Leads the Shift to On?Demand Fashion Kornit Digital LTD. (NASDAQ: KRNT) is pushing the textile world deeper into digital with a clear, practical message: make only what you need, when you need it. At its “Fashion is Choosing On-Demand” event, held alongside PRINTING United Expo 2024, the company put that idea on stage—showing how its technology turns...

Continue Reading
Navigating Business Transitions with ExitWell Advisors

Updated Category News Views 176

Driving Strategic Business Transitions with Expertise ExitWell Advisors is making a significant impact in guiding business owners through the complexities of exit planning and transitions. Founded by the experienced business leader Dave Lokos, the firm focuses on helping owners take control of their future with thoughtful planning and readiness for transactions. With...

Continue Reading
Essential Safety Warnings Issued by the CPSC

Updated Category News Views 91

Safety Alerts from the CPSC In an ongoing effort to protect consumers, the U.S. Consumer Product Safety Commission (CPSC) has announced several alarming safety warnings regarding various products well-known in households today. The CPSC aims to keep families safe from potential dangers associated with consumer products. These warnings reflect a commitment to consumer...

Continue Reading
Denali Therapeutics Shares Promising Results in Hunter Syndrome Study

Updated Category News Views 172

Denali Therapeutics Reveals Phase 1/2 Study Insights Denali Therapeutics Inc. (NASDAQ: DNLI) has recently shared exciting updates from the primary analysis of its Phase 1/2 study investigating tividenofusp alfa (DNL310) for treating Hunter syndrome, also known as MPS II. Conducted with 47 participants during a 24-week treatment phase, this clinical trial has yielded...

Continue Reading
The Future of Autonomous Last Mile Delivery: Market Insights

Updated Category News Views 263

Overview of the Autonomous Last Mile Delivery Market The global autonomous last mile delivery market is experiencing rapid growth, anticipating a value of US$ 185.30 billion by 2033. This signifies a substantial leap from the US$ 30.05 billion valuation in 2024, with a remarkable compound annual growth rate (CAGR) of 22.4%. The increasing demand for efficient logistics...

Continue Reading